KATHRYN WAYNE ANZUETO
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family WARRIOR, AL NPI 1821697285
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family AL GENZYME CORPORATION All categories
General Payments — all program years on this page
$2,235.85
- Category: General Payments
- Program years: PY2021–2024
- Record count: 32
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $569.61 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $569.61 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $187.57 | 1 |
| Janssen Biotech, Inc. | $152.34 | 2 |
| ABBVIE INC. | $124.98 | 1 |
| Kite Pharma, Inc. | $50.37 | 3 |
| Legend Biotech USA Inc. | $29.68 | 1 |
| Stemline Therapeutics Inc. | $24.67 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078265673 | Janssen Biotech, Inc. | $18.15 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1078265675 | Janssen Biotech, Inc. | $134.19 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106447384 | ABBVIE INC. | $124.98 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1128611783 | Kite Pharma, Inc. | $15.81 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1128611785 | Kite Pharma, Inc. | $16.30 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1128611787 | Kite Pharma, Inc. | $18.26 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131692827 | Legend Biotech USA Inc. | $29.68 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139662642 | GENZYME CORPORATION | $187.57 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142968535 | Stemline Therapeutics Inc. | $24.67 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.